These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2832648)

  • 1. Pharmacological studies on the interrelation between the dopaminergic, GABAergic and opioid peptidergic systems in the central nervous system of the rat.
    Kamata K
    Jpn J Pharmacol; 1987 Dec; 45(4):439-47. PubMed ID: 2832648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
    Arenas E; Alberch J; Marsal J
    Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter receptors in the central nervous system and aging: pharmacological aspect (review).
    Burchinsky SG
    Exp Gerontol; 1984; 19(4):227-39. PubMed ID: 6094228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for the existence of interactions between dopaminergic and opioid peptidergic systems in guinea-pig ileum myenteric plexus.
    Vargas ML; Martinez JA; Milanés MV
    Eur J Pharmacol; 1986 Sep; 128(3):259-63. PubMed ID: 3024995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pharmacological analysis of the role of GABA- and opioidergic systems in the development of brain edema].
    Novikov VE; Iasnetsov VV; Sharov AN
    Biull Eksp Biol Med; 1992 Jul; 114(8):163-5. PubMed ID: 1334728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the neuropharmacology of harmane and other beta-carbolines.
    Müller WE; Fehske KJ; Borbe HO; Wollert U; Nanz C; Rommelspacher H
    Pharmacol Biochem Behav; 1981 May; 14(5):693-9. PubMed ID: 6264501
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dopaminergic receptor activity and the evolution of schizophrenia].
    Fodoreanu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
    [No Abstract]   [Full Text] [Related]  

  • 8. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--I. In vivo analysis.
    Nisenbaum ES; Berger TW
    Neuroscience; 1992; 48(3):561-78. PubMed ID: 1318517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of perinatal drug administration on brain development: striatal opiate receptors and dopamine.
    Moon SL
    NIDA Res Monogr; 1985; 62():129-45. PubMed ID: 3001526
    [No Abstract]   [Full Text] [Related]  

  • 10. Future directions in dopaminergic nervous system and dopaminergic agonists.
    Cannon JG; Long JP; Bhatnagar R
    J Med Chem; 1981 Oct; 24(10):1113-8. PubMed ID: 7035666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the dopaminergic system and GABA-benzodiazepine- ionophore complex in the regulation of memory retrieval].
    Dubrovina NI; Il'iuchenok RIu
    Fiziol Zh (1978); 1990; 36(3):3-8. PubMed ID: 1975548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of pharmacological receptors in mammalian central nervous system.
    Banerjee PK; Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1989 Apr; 27(4):310-6. PubMed ID: 2553590
    [No Abstract]   [Full Text] [Related]  

  • 13. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--II. In vitro analysis.
    Nisenbaum ES; Grace AA; Berger TW
    Neuroscience; 1992; 48(3):579-93. PubMed ID: 1351271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic drugs and the sigma receptor.
    Hoffman DW
    Am J Psychiatry; 1990 Aug; 147(8):1093-4. PubMed ID: 1973876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative analysis of the antiamnesic action of a blockade of the benzodiazepine-GABA-ionophore complex and of an activation of the dopaminergic system in the brain of mice].
    Dubrovina NI; Il'iuchënok RIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1054-9. PubMed ID: 2854342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
    Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
    Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of dopaminergic receptor stimulation and opioid receptor blockade on GH incretion: preliminary findings.
    Ghisoli E; Benfenati F; Pancaldi L; Meringolo D; Catenacci M
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1222-5. PubMed ID: 6257257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.
    Shippenberg TS; Herz A
    Eur J Pharmacol; 1988 Jul; 151(2):233-42. PubMed ID: 2844553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opioid receptors of the CNS: function, structure and distribution].
    Slamberová R
    Cesk Fysiol; 2004; 53(4):159-66. PubMed ID: 15704740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.